July 02, 2025

UK Plans Nationwide DNA Sequencing of Newborns

The scheme aims to prevent disease, but some experts are skeptical

The Analytical Scientist

July 01, 2025

The Optimism of Optogenetics

Several companies are sponsoring clinical development of optogenetic therapies, each with distinct approaches and technologies.

Ophthalmology Management

July 01, 2025

The Strategic Value of Real-Time CBCT Validation

Support in ensuring that scans meet clinical standards benefits patients and practices

Inside Dentistry

July 01, 2025

Director of Clinical Resources Group Announces Report on Ocular Risks of Glucagon-Like Peptide-1 Agonists

During the AOA’s 2025 House of Delegates meeting, director of the AOA’s clinical resources group, Andrew Morgenstern, OD, announced the report, “Glucagon-like Peptide-1 Receptor Agonists and Ocular Health: Guidance for Optometric Practice.”

Optometric Management

June 30, 2025

Chinese Herbal Medicine for Improving Adjuvant Chemotherapy Completion in Patients With Colon Cancer

Guest Editor’s Note: Although guidelines recommend adjuvant combination chemotherapy for patients with stage II and III colon cancer who are at high risk of disease recurrence, fewer than 50% complete...

The ASCO Post

June 27, 2025

Also in the News…

The Ophthalmologist brings you the top news stories and studies of the week

The Ophthalmologist

June 27, 2025

Relacorilant and Nab-Paclitaxel in Platinum-Resistant Ovarian Cancer

In a phase III trial (ROSELLA) reported in The Lancet, Olawaiye et al examined the survival benefit of adding relacorilant to nab-paclitaxel in women with platinum-resistant ovarian cancer. Relacorila...

The ASCO Post

June 27, 2025

Weight Loss Drugs, Heavier Implications

New guidance positions GLP-1 and GLP-1/GIP therapies as frontline options for long-term weight management—with profound implications for cardiovascular outcomes, access equity, and chronic disease care.

Conexiant

June 27, 2025

New Guidance Targets Risk-Based Diabetes Care

A new review outlines updated strategies for diagnosing and managing type 2 diabetes, recommending earlier use of SGLT2 inhibitors and GLP-1 receptor agonists in patients with cardiovascular or kidney conditions.

Conexiant